156 related articles for article (PubMed ID: 17437968)
1. A multidisciplinary approach is required to increase the quality of phase II/III clinical studies on biotherapies in oncology.
Ottaiano A; Budillon A; Normanno N; Iaffaioli VR; Caraglia M
Ann Oncol; 2007 May; 18(5):960-1. PubMed ID: 17437968
[No Abstract] [Full Text] [Related]
2. Phase III trials in oncology: setting standards of care?
Seeber S; Braun AH
Nat Clin Pract Oncol; 2005 Sep; 2(9):426-7. PubMed ID: 16264993
[No Abstract] [Full Text] [Related]
3. Prospective clinical trials of biotherapies in solid tumors: a 5-year survey.
Ottaiano A; Mollo E; Di Lorenzo G; Pisano C; Di Maio M; Barletta E; Pensabene M; Segati R; Bullian P; Nasti G; Bryce J; Scala S; Castello G; Ascierto PA
Cancer Immunol Immunother; 2005 Jan; 54(1):44-50. PubMed ID: 15693138
[TBL] [Abstract][Full Text] [Related]
4. Competing Risks in Older Patients With Cancer: A Systematic Review of Geriatric Oncology Trials.
Burdett N; Vincent AD; O'Callaghan M; Kichenadasse G
J Natl Cancer Inst; 2018 Aug; 110(8):825-830. PubMed ID: 30011032
[TBL] [Abstract][Full Text] [Related]
5. Challenges and Opportunities in Dose Finding in Oncology and Immuno-oncology.
Ji Y; Jin JY; Hyman DM; Kim G; Suri A
Clin Transl Sci; 2018 Jul; 11(4):345-351. PubMed ID: 29392871
[No Abstract] [Full Text] [Related]
6. Analysis of the yield of phase II combination therapy trials in medical oncology.
Maitland ML; Hudoba C; Snider KL; Ratain MJ
Clin Cancer Res; 2010 Nov; 16(21):5296-302. PubMed ID: 20837695
[TBL] [Abstract][Full Text] [Related]
7. The phase III candidate: can we improve the science of selection?
Bajorin D
J Clin Oncol; 2004 Jan; 22(2):211-3. PubMed ID: 14665614
[No Abstract] [Full Text] [Related]
8. Response rates, survival, and chemotherapy trials.
Pazdur R
J Natl Cancer Inst; 2000 Oct; 92(19):1552-3. PubMed ID: 11018082
[No Abstract] [Full Text] [Related]
9. Health care disparity: an overlooked problem in phase I oncology trials.
O'Brien TE
J Clin Oncol; 2007 Jul; 25(21):3182-3. PubMed ID: 17634502
[No Abstract] [Full Text] [Related]
10. Appendix 1: Renal cell carcinoma: MCBS eUpdate published online 10 April 2017(www.esmo.org/Guidelines/Genitourinary-Cancers).
ESMO Guidelines Committee
Ann Oncol; 2017 Jul; 28(suppl_4):iv143-iv144. PubMed ID: 28881922
[No Abstract] [Full Text] [Related]
11. Comparison of outcomes of phase II studies and subsequent randomized control studies using identical chemotherapeutic regimens.
Zia MI; Siu LL; Pond GR; Chen EX
J Clin Oncol; 2005 Oct; 23(28):6982-91. PubMed ID: 16192585
[TBL] [Abstract][Full Text] [Related]
12. Highlights from the 40th Annual Meeting of the American Society of Clinical Oncology, New Orleans, LA. June 2004.
Lee D; Price N; Reddy K
Clin Prostate Cancer; 2004 Sep; 3(2):73-6. PubMed ID: 15479487
[No Abstract] [Full Text] [Related]
13. A comparison of phase II study strategies.
Hunsberger S; Zhao Y; Simon R
Clin Cancer Res; 2009 Oct; 15(19):5950-5. PubMed ID: 19789306
[TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary treatment of rectal cancer: medical oncology.
Aschele C; Lonardi S
Ann Oncol; 2007 Jul; 18 Suppl 9():ix114-21. PubMed ID: 17631563
[No Abstract] [Full Text] [Related]
15. The group sequential triangular test for phase II cancer clinical trials.
Bellissant E; Bénichou J; Chastang C
Am J Clin Oncol; 1996 Aug; 19(4):422-30. PubMed ID: 8677918
[TBL] [Abstract][Full Text] [Related]
16. Servier's pipeline in oncology: moving from research to patients.
Therasse P; Abastado JP
Future Oncol; 2016 Mar; 12(5):589-94. PubMed ID: 26764971
[No Abstract] [Full Text] [Related]
17. Combination therapies in oncology.
Webster RM
Nat Rev Drug Discov; 2016 Feb; 15(2):81-2. PubMed ID: 26837588
[No Abstract] [Full Text] [Related]
18. Appendix 1: Cancer of the Prostate: eUpdate published online 28 September 2017 (http://www.esmo.org/Guidelines/Genitourinary-Cancers/Cancer-of-the-Prostate).
ESMO Guidelines Committee
Ann Oncol; 2018 Oct; 29(Suppl 4):iv256. PubMed ID: 30285212
[No Abstract] [Full Text] [Related]
19. Improving the institutional submission and approval process for clinical research protocols in oncology.
Camacho LH; Marubio L; Purdom MA; Leonard D; Hong DS; Moulder S; Pilat SR; Kurzrock R
J Clin Oncol; 2007 Apr; 25(12):1632-3. PubMed ID: 17443009
[No Abstract] [Full Text] [Related]
20. Current studies with docetaxel in hormone-refractory prostate cancer: selected presentations from the 27th European Society for Medical Oncology Congress, 2002.
DeGrendele H
Clin Prostate Cancer; 2003 Mar; 1(4):212-4. PubMed ID: 15040878
[No Abstract] [Full Text] [Related]
[Next] [New Search]
